Stephen D Nimer

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

M. Millenson, P. Westervelt, G. Garcia-Manero, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)

R. Bejar, U. Borate, J. Giesinger, 2024, HemaSphere.